Skip to main content
Skip to content
Case File
sd-10-EFTA01457563Dept. of JusticeOther

EFTA Document EFTA01457563

II May 2015 Pharmaceuticals GlazeSmithKline [Figure 14: Core P&L forecasts G(iPm Sales Growth I%) FYI4A 23.000 -10.1% rr Hi( 24,402 6.1% f-Y16E 26,919 3.7% F't i 7l: 26.105 3.1% F, i I SE 28,797 2.7% 819E 27.247 1.7% i Y20( 29.217 3.6% ...Pharmaceuticals 18.670 18,184 18,456 18,979 19,386 19,546 20.218 ...Consumer Health 4.336 6,218 6,868 7.128 7,412 7.701 7.999 Cost of sales -6.535 -7,985 -8,179 -8.477 -8.956 -9,088 8,315 Gross Profit 16,471

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01457563
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

II May 2015 Pharmaceuticals GlazeSmithKline [Figure 14: Core P&L forecasts G(iPm Sales Growth I%) FYI4A 23.000 -10.1% rr Hi( 24,402 6.1% f-Y16E 26,919 3.7% F't i 7l: 26.105 3.1% F, i I SE 28,797 2.7% 819E 27.247 1.7% i Y20( 29.217 3.6% ...Pharmaceuticals 18.670 18,184 18,456 18,979 19,386 19,546 20.218 ...Consumer Health 4.336 6,218 6,868 7.128 7,412 7.701 7.999 Cost of sales -6.535 -7,985 -8,179 -8.477 -8.956 -9,088 8,315 Gross Profit 16,471

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
II May 2015 Pharmaceuticals GlazeSmithKline [Figure 14: Core P&L forecasts G(iPm Sales Growth I%) FYI4A 23.000 -10.1% rr Hi( 24,402 6.1% f-Y16E 26,919 3.7% F't i 7l: 26.105 3.1% F, i I SE 28,797 2.7% 819E 27.247 1.7% i Y20( 29.217 3.6% ...Pharmaceuticals 18.670 18,184 18,456 18,979 19,386 19,546 20.218 ...Consumer Health 4.336 6,218 6,868 7.128 7,412 7.701 7.999 Cost of sales -6.535 -7,985 -8,179 -8.477 -8.956 -9,088 8,315 Gross Profit 16,471 16,417 17.134 17.628 17.841 18.159 18,902 Gross margin 71.6% 67.3% 67.7% 67.5% 66.6% 66.6% 67.0% SG&A -7,074 -7,444 -7,447 -7,429 -7,547 -7,593 -7.840 %of sales 30.7% 30.6% 29.4% 26.5% 28.2% 27.9% 27.8% R&D -3,113 -3,309 -3,394 -3.385 -3,281 -3,338 -3,461 %of sales 13.6% 13.6% 13.4% 13,0% 12.2% 12.2% 12.3% Royalty income 310 274 285 296 309 300 292 OPoroth9 profit 6.694 5.937 6.678 7.111 7.321 7.629 7.893 %of sales 28.7% 24.3% 26.0% 27.2% 27.3% 27.6% 28.0% Net interest -646 -621 -477 -473 -626 -657 -606 JVs & associates 30 7 -3 -3 -3 -3 -3 Profit before tax 5,978 5,324 6098 6.634 6,693 6,869 7.296 Tax expense -1,172 -1,036 -1,201 -1,287 -1278 -1.305 -1,384 Profit after tax 4.800 4,259 4.997 5347 5,414 6,664 6.901 ...minority share -222 -474 -665 -749 -566 -484 -510 ...shareholders' share 4,584 3,785 4.232 4,599 4,849 5.080 5.392 Cots EPS. bait (p) 96.4 79.3 87.8 96.3 100A 105.1 111.4 Cons EPS, diluted (p) 94.2 77.4 93.9 94.2 992 103.9 110.1 DB adjusted Con EPS (p) 93.9 759 94.3 91.1 95.5 99.6 105.4 Ord ONIdend per Oars (p) 90.0 100.0 90.0 80.0 80.0 90.0 90.0 San (ALTO.. &ant • inlet Crow Ste Deutsche Bank AG/London l'Age I I CONFIDENTIAL — PURSUANT TO FED. R CRIM. P. 6(e) DB-SDNY-0117161 CONFIDENTIAL SDNY_GM_00263345 EFTA01457563

Related Documents (6)

Dept. of JusticeOtherUnknown

EFTA Document EFTA01392803

Accouprge and Joint Application Information Name of of Account Title Joint Applicant (last name,,,Qrst name, rpiddle initleq o st name, first name, middle Socjal Secursr Num:deep; TaxpaYerAD Numb?' S /foe R6.0 t" at VA143efer.; /vow City, State and Zip C e Social Security Number or Taxpayer ID Number Address City. State and Zip Code Business Telephone Numbe Nome Telephone Number Business Telephone Number Date of Birth Date of birth Name of Employer Address City, State and

1p
OtherUnknown

KYC Print

DOJ EFTA Data Set 10 document EFTA01299082

15p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01361145

Growth Strategy returns Performance' for taxable client ending 3/31/15 CIO Strategies w/ U.S. Core Equity as U.S. Large Cap Vehicle ® Blended Benchmark 6 - 4 2 - 0 3.51 1.93 1Q15 C [0 Strategies .. Growth Blended Benchmark 9.78 8.30 8.42 4.15 1 Year 9.27 7.98 3 Year 5 Year °A Annualized Performance Gross of Fees 7.35 5.88 10 Year 7.07 2014 2013 2012 2011 2010 2009 2008 2007 4.84% 17.64% 14.43-;•:.. -2.94% 13.79% 29.09% 30.42% 12.52% 3.40% 16.25% 1

1p
Dept. of JusticeAug 22, 2017

15 July 7 2016 - July 17 2016 working progress_Redacted.pdf

Kristen M. Simkins From: Sent: To: Cc: Subject: Irons, Janet < Tuesday, July 12, 2016 10:47 AM Richard C. Smith     Hello Warden Smith,     mother is anxious to hear the results of your inquiry into her daughter's health.   I'd be grateful if you could  email or call me at your earliest convenience.  I'm free today after 2 p.m.  Alternatively, we could meet after the Prison  Board of Inspectors Meeting this coming Thursday.    Best wishes,    Janet Irons    1 Kristen M. Simkins From: Sent:

1196p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01392712

Account Title and Joint Application Information Zorro Development Corp Name of Account Title Joint A,oplitant Omar Business pest nave, first name. middle initial) rocTalSeCutitY Number or Taxpayer ID Number Social Seavity Mentor or Taxpayer ID Number Clop Agee Wove ategvetc9? 63 Address, Address St ThOnielc 0090•2—' State and Zi Code Horne Telephone Nirnter Bush ass Telephone Number I Date or firth Name of Employer Address City, State and Lp Code Notice of Customer Id

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01384801

Emai Securities offered through Deutsche Bank Securities Inc. From: Vijay-A Sawant Sent: Wednesday. September 26, 2018 6:02 AM To: Stewart Oldfie Cc: Bradley Gilli ; Richard larossi Alka Babu Subject: RE: Southern Financial Importance: High Hello Stewan_ ; Mayur Rathod We have some good news in that regard. We has 0 977698 & 01946825) which got approved in this past week. These cases cover high risked accounts Prytanee, LL . Neptune. LLC & Butterfly Trust. We arc in the process

1p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.